Quanterix (QTRX) Total Current Liabilities (2017 - 2026)
Quanterix's (QTRX) quarterly Total Current Liabilities came in at $49.9 million in Q1 2026, up 23.54% YoY from $40.4 million in Q1 2025, and down 33.25% on a QoQ basis from $74.8 million in Q4 2025.
Quanterix (QTRX) Total Current Liabilities (2017 - 2026) Analysis & Trends
Quanterix (QTRX) has 10 years of Total Current Liabilities data on file, last reported at $49.9 million in Q1 2026.
- Quarterly Total Current Liabilities rose 23.54% year-over-year to $49.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.9 million (up 23.54% YoY) and the FY2025 annual result came in at $74.8 million, up 77.98% from the prior year.
- Total Current Liabilities eased to $49.9 million in Q1 2026, from $74.8 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $77.4 million in Q3 2025 to a low of $27.5 million in Q1 2023.
- A 5-year average of $41.4 million and a median of $36.7 million in 2022 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities declined 15.22% — and 2025, when it soared 112.19%.
- Tracing QTRX's Total Current Liabilities over 5 years: stood at $31.3 million in 2022, then rose by 24.35% to $39.0 million in 2023, then rose by 7.76% to $42.0 million in 2024, then jumped by 77.98% to $74.8 million in 2025, then tumbled by 33.25% to $49.9 million in 2026.
- The last three Total Current Liabilities figures came in at $49.9 million (Q1 2026), $74.8 million (Q4 2025), and $77.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Quanterix | 146.22 Mn | 52.69 Mn | 12.67 Mn | 50.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 50.37 Mn |
| Mar 31, 2026 | 49.91 Mn |
| Dec 31, 2025 | 74.76 Mn |
| Sep 30, 2025 | 77.35 Mn |
| Jun 30, 2025 | 48.20 Mn |
| Mar 31, 2025 | 40.40 Mn |
| Dec 31, 2024 | 42.01 Mn |
| Sep 30, 2024 | 36.45 Mn |
| Jun 30, 2024 | 38.14 Mn |
| Mar 31, 2024 | 32.76 Mn |
| Dec 31, 2023 | 38.98 Mn |
| Sep 30, 2023 | 35.90 Mn |
| Jun 30, 2023 | 32.61 Mn |
| Mar 31, 2023 | 27.48 Mn |
| Dec 31, 2022 | 31.35 Mn |
| Sep 30, 2022 | 28.92 Mn |
| Jun 30, 2022 | 36.73 Mn |
| Mar 31, 2022 | 31.76 Mn |
| Dec 31, 2021 | 36.98 Mn |
| Sep 30, 2021 | 31.19 Mn |